As of November 6, 2026, AngioDynamics, Inc. is a publicly traded company (Nasdaq: ANGO); its largest reported holder is Point72, with 7.7% on Schedule 13G/A of May 15, 2026, then Systematic Financial Management LP (6.1%). The largest insider holding is James C. Clemmer, the chief executive and president, with 862,448 shares (2.1% of shares outstanding), per Form 4 of July 24, 2026 (Schedule 13G/A, May 15, 2026).
Is this your company?
About to sign with, pay or invest in AngioDynamics, Inc.? See the free Snapshot first.
Free to see. No signup.
Is AngioDynamics, Inc. a real, registered company?
- AngioDynamics, Inc. files with the SEC under CIK 1275187 (its SEC filings).
- Its shares are listed under the ticker ANGO on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Latham, New York, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under AngioDynamics, Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Layoffs: 3 state WARN notices (latest 2025-11-13, Glens Falls NY, 1 employees).
- Leadership changes: the latest reported is Eric Honroth, President and Chief Executive Officer (Form 8-K filed 2026-10-08). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Point72 (filed 2026-05-15).
Who are AngioDynamics, Inc.'s owners and officers?
AngioDynamics, Inc.: incorporated in Delaware; business address in Latham, New York; industry Surgical & Medical Instruments & Apparatus (Form D, 2026-10-08).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-05-15 | Point72 Asset Management, L.P. | 7.7% |
| Schedule 13G/A, 2026-03-26 | The Vanguard Group | 0% |
| Schedule 13G/A, 2026-02-13 | Divisadero Street Capital Management, LP | 0.01% |
| Schedule 13G, 2026-02-10 | Systematic Financial Management LP | 6.1% |
| Schedule 13G, 2026-02-09 | Kevin Kotler | 5.9% |
| Schedule 13G/A, 2026-01-08 | Millennium Management LLC | 2% |
| Schedule 13G/A, 2025-11-14 | Point72 Asset Management, L.P. | 6.2% |
| Schedule 13G/A, 2025-08-14 | Armistice Capital, LLC | 3.76% |
| Schedule 13G/A, 2025-08-13 | Divisadero Street Capital Management, LP | 8.4% |
| Schedule 13G, 2025-07-22 | Millennium Management LLC | 5.3% |
| Schedule 13G, 2025-07-17 | Point72 Asset Management, L.P. | 5.2% |
Questions about who owns AngioDynamics, Inc.
Who owns AngioDynamics, Inc.?
On this page, 3 holders' latest ownership filings report 5% or more of AngioDynamics, Inc.: Point72 Asset Management, L.P. (7.7%, Schedule 13G/A, filed 2026-05-15), Systematic Financial Management LP (6.1%, Schedule 13G, filed 2026-02-10) and Kevin Kotler (5.9%, Schedule 13G, filed 2026-02-09).
Who are the largest shareholders of AngioDynamics, Inc.?
By the share each holder's latest filing reports, the largest holders of AngioDynamics, Inc. on this page are Point72 Asset Management, L.P. (7.7%), Systematic Financial Management LP (6.1%) and Kevin Kotler (5.9%).
When did Point72 Asset Management, L.P. buy into AngioDynamics, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Point72 Asset Management, L.P. on this page is the Schedule 13G, filed 2025-07-17, reporting 5.2%; its latest, Schedule 13G/A filed 2026-05-15, reports 7.7%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 11 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on AngioDynamics, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on AngioDynamics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on AngioDynamics, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
19 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-10-08 | Eric Honroth | President and Chief Executive Officer | appointed | 2026-11-02 |
| Form 8-K, 2026-10-08 | Howard W. Donnelly | Director | departed |
Which insiders own AngioDynamics, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief executive and president: 862,448 shares (2.1% of shares outstanding) (Form 4, 2026-07-24).
- , the chief financial officer and executive vice president: 280,461 shares (0.67% of shares outstanding) (Form 4, 2026-10-30).
- , a director: 178,938 shares (0.43% of shares outstanding) (Form 4, 2026-07-22).
- , a director: 155,425 shares (0.37% of shares outstanding) (Form 4, 2026-07-22).
- , a director: 116,921 shares (0.28% of shares outstanding) (Form 4, 2026-07-22).
Shares outstanding: 42,054,450 as of 2026-10-07, from the company's latest SEC cover page.
How much has AngioDynamics, Inc. raised?
No fundraising or offering filing from AngioDynamics, Inc. is on file with us.
Keep reading
More on AngioDynamics, Inc. and the records around it.
AngioDynamics, Inc. elsewhere on the record
- Leadership changes Oct 2026
- 5%+ stake filings May 2026
Companies that share a holder
- SYSTEMATIC FINANCIAL MANAGEMENT LP also filed stake reports on 8 other companies: KVH INDUSTRIES INC \DE\ (Aug 2026), LSI INDUSTRIES INC (Aug 2026), MAGNACHIP SEMICONDUCTOR Corp (Feb 2026)
- Divisadero Street Capital Management, LP also filed stake reports on 22 other companies: Rush Street Interactive, Inc. (Sep 2026), Build-a-Bear Workshop, Inc (Aug 2026), Citi Trends, Inc. (Aug 2026)
- Integrated Core Strategies (US) LLC also filed stake reports on 63 other companies: SkinHealth Systems Inc. (Nov 2026), Infinite Eagle Acquisition Corp. (Nov 2026), Longeveron Inc. (Nov 2026)
Related pages
LayoffsLeadership changes5%+ holders
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/angiodynamics